患者エンゲージメント市場におけるAIの成長と動向分析レポート

AI In Patient Engagement Market Growth & Trends

The global AI in patient engagement market size is expected to reach USD 23.1 billion by 2030, registering a CAGR of 21.2% from 2024 to 2030, according to a new report by Grand View Research, Inc.

世界の患者エンゲージメントにおけるAI 市場規模は 2030 年までに 231 億米ドルに達すると予想されており、2024 年から 2030 年にかけて 21.2% の CAGR を記録します。

The market is driven by the growing demand for AI-based personalized treatment plans and healthcare experiences and the emergence of digital platforms and necessity for omnichannel approach. In addition, the increasing role of artificial intelligence (AI) in enhancing pharmacy efficiency and managing supply chain complexities and business strategies by market players is also driving the market growth. For instance, in May 2024, EmpiRx Health introduced Clinically, a new AI-powered platform that incorporates established technologies. This platform enhances pharmacy claims processing and clinical evaluations and includes a unique population health engine, reinforcing EmpiRx Health’s clinical-focused Pharmacy Benefit Management (PBM) approach.

Moreover, the growing prevalence of chronic diseases, such as diabetes and hypertension, necessitates continuous patient engagement & management, which AI can effectively facilitate. Furthermore, AI technologies such as machine learning and natural language processing (NLP) can significantly enhance patient engagement by providing personalized support & interventions. These technologies analyze patient data to offer tailored recommendations, reminders, & educational content, improving adherence and health outcomes. For instance, in March 2022, Uniphore entered into a strategic partnership with SpinSci Technologies, a provider of digital patient engagement solutions, to improve patient access and interaction with healthcare providers. This collaboration integrated Uniphore’s conversational AI and automation technology into SpinSci Technologies Patient Access Care solutions, which are compatible with Electronic Health Records (EHR) systems. The integration aimed to enhance efficiency for contact center agents and streamline patient self-service workflows.

AI In Patient Engagement Market Report Scope

The integration of AI enables healthcare organizations to deliver tailored educational content based on individual patient preferences, health literacy levels, and language proficiency, thereby improving patient engagement & adherence to treatment plans. For instance, in February 2024, Ascend, a startup platform backed by the Accolade Group, announced its intention to deliver educational and healthcare services tailored to specific requirements utilizing AI. As a result of such initiatives, the patient education functionality segment is expected to witness substantial growth, driving overall market expansion in the coming years.

In addition, the market in North America is driven by the integration of AI, enabling healthcare organizations to deliver tailored educational content based on individual patient preferences, health literacy levels, and language proficiency, thereby improving patient engagement & adherence to treatment plans. For instance, in February 2024, Ascend, a startup platform backed by the Accolade Group, announced its intention to deliver educational and healthcare services tailored to specific requirements utilizing AI. As a result of such initiatives, the patient education functionality segment is expected to witness substantial growth, driving overall market expansion in the coming years.

AI In Patient Engagement Market Report Highlights

• On the basis of delivery mode, the cloud-based segment dominated the market and held a revenue share of 72.37% in 2023. Cloud-based solutions provide scalable resources, enabling healthcare organizations to adjust capacity according to demand fluctuations

• On the basis of functionality, enhanced communication held the largest revenue share of 25.84% in 2023. The growing integration of AI-driven solutions in the healthcare sector is driving the need for enhanced communication capabilities

• On the basis of technology, Natural Language Processing (NLP) held the largest revenue share of 88.82% in 2023. The segment growth can be attributed to several benefits offered by NLP models such as improved patient engagement and education through the provision of tailored & comprehensible health information

• On the basis of therapeutic area, chronic disease management held the largest revenue share of 64.87% in 2023. The segment growth can be attributed to the increasing prevalence of chronic conditions such as diabetes, hypertension, and heart disease

• On the basis of end use, the healthcare providers segment held the largest revenue share of 38.31% in 2023. The increasing focus on patient-centric care, coupled with the growing need for effective use of resources and a rising demand for personalized healthcare experiences, is driving healthcare providers to adopt AI for patient engagement

• North America dominated the market with a share of 43.60% in 2023. Key factors contributing to this notable share include the presence of a well-established healthcare infrastructure equipped with advanced technology, increasing awareness of the advantages of integrating AI-enabled patient engagement solutions, and a growing preference for personalized healthcare experiences & treatment plans

• The market is fragmented owing to the presence of several players. This is expected to intensify the competition in the coming years. Key companies are increasingly adopting strategies such as new product development, collaborations, and mergers & acquisitions to strengthen their market position. In June 2024, MedAdvisor Solutions announced the launch of Omnichannel Engagement for Pharmacy powered by THRiV, its AI-enabled platform. This suite enables pharmacies to enhance their digital patient engagement strategies and existing initiatives, including providing paperless options increasingly preferred by patients

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope

1.1.1. Technology

1.1.2. Therapeutic Area

1.1.3. Functionality

1.1.4. Delivery Type

1.1.5. End Use

1.2. Research Methodology

1.3. Information Procurement

1.3.1. Purchased database.

1.3.2. GVR’s internal database

1.3.3. Secondary sources

1.3.4. Primary research

1.3.5. Details of primary research

1.4. Information or Data Analysis

1.4.1. Data analysis models

1.5. Market Formulation & Validation

1.6. Model Details

1.6.1. Commodity flow analysis (Model 1)

1.6.2. Approach 1: Commodity flow approach

1.6.3. Volume price analysis (Model 2)

1.6.4. Approach 2: Volume price analysis

1.7. List of Secondary Sources

1.8. List of Primary Sources

1.9. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook

2.2. Segment Outlook

2.2.1. Technology Outlook

2.2.2. Therapeutic Area Outlook

2.2.3. Functionality Outlook

2.2.4. Delivery Outlook

2.2.5. End Use Outlook

2.2.6. Regional outlook

2.3. Competitive Insights

Chapter 3. Artificial Intelligence (AI) in Patient Engagement Market Variables, Trends & Scope

3.1. Market Lineage Outlook

3.1.1. Parent market outlook

3.1.2. Related/ancillary market outlook

3.2. Market Dynamics

3.2.1. Market driver analysis

3.2.2. Market restraint analysis

3.3. Artificial Intelligence (AI) in Patient Engagement Market Analysis Tools

3.3.1. Industry Analysis – Porter’s

3.3.1.1. Supplier power

3.3.1.2. Buyer power

3.3.1.3. Substitution threat

3.3.1.4. Threat of new entrant

3.3.1.5. Competitive rivalry

3.3.2. PESTEL Analysis

3.3.2.1. Political landscape

3.3.2.2. Technological landscape

3.3.2.3. Economic landscape

3.3.3. Impact of COVID-19

3.3.4. Case Study

Chapter 4. Artificial Intelligence (AI) in Patient Engagement Market Delivery Type Estimates & Trend Analysis

4.1. Delivery Type Market Share, 2023 & 2030

4.2. Segment Dashboard

4.3. Global Artificial Intelligence (AI) in Patient Engagement Market by Delivery Type Outlook

4.4. Cloud-based

4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)

4.5. On-premise

4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Artificial Intelligence (AI) in Patient Engagement Market Functionality Estimates & Trend Analysis

5.1. Functionality Market Share, 2023 & 2030

5.2. Segment Dashboard

5.3. Global Artificial Intelligence (AI) in Patient Engagement Market by Functionality Outlook

5.4. Enhanced Communication

5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)

5.5. Patient Education

5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

5.6. Chabot & Virtual Health Assistants

5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

5.7. Predictive Analytics

5.7.1. Market estimates and forecast 2018 to 2030 (USD Million)

5.8. Administrative & Streamlined Operations

5.8.1. Market estimates and forecast 2018 to 2030 (USD Million)

5.9. Others

5.9.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Artificial Intelligence (AI) in Patient Engagement Market Technology Type Estimates & Trend Analysis

6.1. Technology Type Market Share, 2023 & 2030

6.2. Segment Dashboard

6.3. Global Artificial Intelligence (AI) in Patient Engagement Market by Technology Type Outlook

6.4. NLP

6.4.1. Market estimates and forecast 2018 to 2030 (USD Million)

6.4.2. Smart Assistance

6.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)

6.4.3. Optical Character Recognition (OCR)

6.4.3.1. Market estimates and forecast 2018 to 2030 (USD Million)

6.4.4. Auto Coding

6.4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)

6.4.5. Text Analytics

6.4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

6.4.6. Speech Analytics

6.4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

6.4.7. Classification & Categorization

6.4.7.1. Market estimates and forecast 2018 to 2030 (USD Million)

6.5. Others

6.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

6.5.1.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Artificial Intelligence (AI) in Patient Engagement Market Therapeutic Area Estimates & Trend Analysis

7.1. Therapeutic Area Market Share, 2023 & 2030

7.2. Segment Dashboard

7.3. Global Artificial Intelligence (AI) in Patient Engagement Market by Therapeutic Area Outlook

7.4. Health & Wellness

7.4.1. Market estimates and forecast 2018 to 2030 (USD Million)

7.5. Chronic Disease Management

7.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

7.6. Others

7.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 8. Artificial Intelligence (AI) in Patient Engagement Market End Use Estimates & Trend Analysis

8.1. End Use Market Share, 2023 & 2030

8.2. Segment Dashboard

8.3. Global Artificial Intelligence (AI) in Patient Engagement Market by End Use Outlook

8.4. Healthcare Provider

8.4.1. Market estimates and forecast 2018 to 2030 (USD Million)

8.5. Healthcare Payers

8.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

8.6. Others

8.6.1. Pharmaceutical Companies

8.6.1.1. Market estimates and forecast 2018 to 2030 (USD Million)

8.6.2. Pharmacy

8.6.2.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 9. Artificial Intelligence (AI) in Patient Engagement Market Regional Estimates & Trend Analysis, By Component, By Technology Type

9.1. Regional Market Share Analysis, 2023 & 2030

9.2. Regional Market Dashboard

9.3. Global Regional Market Snapshot

9.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:

9.5. North America

9.5.1. U.S.

9.5.1.1. Key country dynamics

9.5.1.2. Regulatory framework/ reimbursement structure

9.5.1.3. Competitive scenario

9.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)

9.5.2. Canada

9.5.2.1. Key country dynamics

9.5.2.2. Regulatory framework/ reimbursement structure

9.5.2.3. Competitive scenario

9.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)

9.5.3. Mexico

9.5.3.1. Key country dynamics

9.5.3.2. Regulatory framework/ reimbursement structure

9.5.3.3. Competitive scenario

9.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)

9.6. Europe

9.6.1. UK

9.6.1.1. Key country dynamics

9.6.1.2. Regulatory framework/ reimbursement structure

9.6.1.3. Competitive scenario

9.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)

9.6.2. Germany

9.6.2.1. Key country dynamics

9.6.2.2. Regulatory framework/ reimbursement structure

9.6.2.3. Competitive scenario

9.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)

9.6.3. France

9.6.3.1. Key country dynamics

9.6.3.2. Regulatory framework/ reimbursement structure

9.6.3.3. Competitive scenario

9.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)

9.6.4. Italy

9.6.4.1. Key country dynamics

9.6.4.2. Regulatory framework/ reimbursement structure

9.6.4.3. Competitive scenario

9.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)

9.6.5. Spain

9.6.5.1. Key country dynamics

9.6.5.2. Regulatory framework/ reimbursement structure

9.6.5.3. Competitive scenario

9.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)

9.6.6. Norway

9.6.6.1. Key country dynamics

9.6.6.2. Regulatory framework/ reimbursement structure

9.6.6.3. Competitive scenario

9.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)

9.6.7. Sweden

9.6.7.1. Key country dynamics

9.6.7.2. Regulatory framework/ reimbursement structure

9.6.7.3. Competitive scenario

9.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)

9.6.8. Denmark

9.6.8.1. Key country dynamics

9.6.8.2. Regulatory framework/ reimbursement structure

9.6.8.3. Competitive scenario

9.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)

9.7. Asia Pacific

9.7.1. Japan

9.7.1.1. Key country dynamics

9.7.1.2. Regulatory framework/ reimbursement structure

9.7.1.3. Competitive scenario

9.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)

9.7.2. China

9.7.2.1. Key country dynamics

9.7.2.2. Regulatory framework/ reimbursement structure

9.7.2.3. Competitive scenario

9.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)

9.7.3. India

9.7.3.1. Key country dynamics

9.7.3.2. Regulatory framework/ reimbursement structure

9.7.3.3. Competitive scenario

9.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)

9.7.4. Australia

9.7.4.1. Key country dynamics

9.7.4.2. Regulatory framework/ reimbursement structure

9.7.4.3. Competitive scenario

9.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)

9.7.5. South Korea

9.7.5.1. Key country dynamics

9.7.5.2. Regulatory framework/ reimbursement structure

9.7.5.3. Competitive scenario

9.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)

9.7.6. Singapore

9.7.6.1. Key country dynamics

9.7.6.2. Regulatory framework/ reimbursement structure

9.7.6.3. Competitive scenario

9.7.6.4. Singapore market estimates and forecasts 2018 to 2030 (USD Million)

9.8. Latin America

9.8.1. Brazil

9.8.1.1. Key country dynamics

9.8.1.2. Regulatory framework/ reimbursement structure

9.8.1.3. Competitive scenario

9.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)

9.8.2. Argentina

9.8.2.1. Key country dynamics

9.8.2.2. Regulatory framework/ reimbursement structure

9.8.2.3. Competitive scenario

9.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)

9.9. MEA

9.9.1. South Africa

9.9.1.1. Key country dynamics

9.9.1.2. Regulatory framework/ reimbursement structure

9.9.1.3. Competitive scenario

9.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)

9.9.2. Saudi Arabia

9.9.2.1. Key country dynamics

9.9.2.2. Regulatory framework/ reimbursement structure

9.9.2.3. Competitive scenario

9.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)

9.9.3. UAE

9.9.3.1. Key country dynamics

9.9.3.2. Regulatory framework/ reimbursement structure

9.9.3.3. Competitive scenario

9.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)

9.9.4. Kuwait

9.9.4.1. Key country dynamics

9.9.4.2. Regulatory framework/ reimbursement structure

9.9.4.3. Competitive scenario

9.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

10.1. Recent Developments & Impact Analysis, By Key Market Participants

10.2. Company/Competition Categorization

10.3. Innovators

10.4. Vendor Landscape

10.4.1. Key company market position analysis, 2023

10.4.2. Medadvisor Solutions

10.4.2.1. Company overview

10.4.2.2. Financial performance

10.4.2.3. Product benchmarking

10.4.2.4. Strategic initiatives

10.4.3. Innovaccer Inc.

10.4.3.1. Company overview

10.4.3.2. Financial performance

10.4.3.3. Product benchmarking

10.4.3.4. Strategic initiatives

10.4.4. EnlivenHealth (Omnicell)

10.4.4.1. Company overview

10.4.4.2. Financial performance

10.4.4.3. Product benchmarking

10.4.4.4. Strategic initiatives

10.4.5. EmpiRx Health

10.4.5.1. Company overview

10.4.5.2. Financial performance

10.4.5.3. Product benchmarking

10.4.5.4. Strategic initiatives

10.4.6. IBM.

10.4.6.1. Company overview

10.4.6.2. Financial performance

10.4.6.3. Product benchmarking

10.4.6.4. Strategic initiatives

10.4.7. Huma

10.4.7.1. Company overview

10.4.7.2. Financial performance

10.4.7.3. Product benchmarking

10.4.7.4. Strategic initiatives

10.4.8. mPulse Mobile

10.4.8.1. Company overview

10.4.8.2. Financial performance

10.4.8.3. Product benchmarking

10.4.8.4. Strategic initiatives

10.4.9. AllazoHealth

10.4.9.1. Company overview

10.4.9.2. Financial performance

10.4.9.3. Product benchmarking

10.4.9.4. Strategic initiatives

10.4.10. P360

10.4.10.1. Company overview

10.4.10.2. Financial performance

10.4.10.3. Product benchmarking

10.4.10.4. Strategic initiatives

10.4.11. Brand Engagement Network, Inc.

10.4.11.1. Company overview

10.4.11.2. Financial performance

10.4.11.3. Product benchmarking

10.4.11.4. Strategic initiatives

10.4.12. Oracle

10.4.12.1. Company overview

10.4.12.2. Financial performance

10.4.12.3. Product benchmarking

10.4.12.4. Strategic initiatives

10.4.13. Nuance Communications Inc. (Microsoft)

10.4.13.1. Company overview

10.4.13.2. Financial performance

10.4.13.3. Product benchmarking

10.4.13.4. Strategic initiatives

10.4.14. Health Catalyst

10.4.14.1. Company overview

10.4.14.2. Financial performance

10.4.14.3. Product benchmarking

10.4.14.4. Strategic initiatives

10.4.15. Ada Health GmbH

10.4.15.1. Company overview

10.4.15.2. Financial performance

10.4.15.3. Product benchmarking

10.4.15.4. Strategic initiatives

10.4.16. Aiva Inc.

10.4.16.1. Company overview

10.4.16.2. Financial performance

10.4.16.3. Product benchmarking

10.4.16.4. Strategic initiatives

10.4.17. Claritas Rx

10.4.17.1. Company overview

10.4.17.2. Financial performance

10.4.17.3. Product benchmarking

10.4.17.4. Strategic initiatives

10.4.18. AiCure

10.4.18.1. Company overview

10.4.18.2. Financial performance

10.4.18.3. Product benchmarking

10.4.18.4. Strategic initiatives

10.4.19. UST Global Inc.

10.4.19.1. Company overview

10.4.19.2. Financial performance

10.4.19.3. Product benchmarking

10.4.19.4. Strategic initiatives

10.4.20. ZS

10.4.20.1. Company overview

10.4.20.2. Financial performance

10.4.20.3. Product benchmarking

10.4.20.4. Strategic initiatives

10.4.21. IQVIA, Inc.

10.4.21.1. Company overview

10.4.21.2. Financial performance

10.4.21.3. Product benchmarking

10.4.21.4. Strategic initiatives

List of Tables

List of Tables

Table 1 List of abbreviation

Table 2 North America AI in patient engagement market, by region, 2018 – 2030 (USD Million)

Table 3 North America AI in patient engagement market, by delivery mode, 2018 – 2030 (USD Million)

Table 4 North America AI in patient engagement market, by functionality, 2018 – 2030 (USD Million)

Table 5 North America AI in patient engagement market, by technology, 2018 – 2030 (USD Million)

Table 6 North America AI in patient engagement market, by therapeutic area, 2018 – 2030 (USD Million)

Table 7 North America AI in patient engagement market, by end-use, 2018 – 2030 (USD Million)

Table 8 U.S. AI in patient engagement market, by delivery mode, 2018 – 2030 (USD Million)

Table 9 U.S. AI in patient engagement market, by functionality, 2018 – 2030 (USD Million)

Table 10 U.S. AI in patient engagement market, by technology, 2018 – 2030 (USD Million)

Table 11 U.S. AI in patient engagement market, by therapeutic area, 2018 – 2030 (USD Million)

Table 12 U.S. AI in patient engagement market, by end-use, 2018 – 2030 (USD Million)

Table 13 Canada AI in patient engagement market, by delivery mode, 2018 – 2030 (USD Million)

Table 14 Canada AI in patient engagement market, by functionality, 2018 – 2030 (USD Million)

Table 15 Canada AI in patient engagement market, by technology, 2018 – 2030 (USD Million)

Table 16 Canada AI in patient engagement market, by therapeutic area, 2018 – 2030 (USD Million)

Table 17 Canada AI in patient engagement market, by end-use, 2018 – 2030 (USD Million)

Table 18 Mexico AI in patient engagement market, by delivery mode, 2018 – 2030 (USD Million)

Table 19 Mexico AI in patient engagement market, by functionality, 2018 – 2030 (USD Million)

Table 20 Mexico AI in patient engagement market, by technology, 2018 – 2030 (USD Million)

Table 21 Mexico AI in patient engagement market, by therapeutic area, 2018 – 2030 (USD Million)

Table 22 Mexico AI in patient engagement market, by end-use, 2018 – 2030 (USD Million)

Table 23 Europe AI in patient engagement market, by region, 2018 – 2030 (USD Million)

Table 24 Europe AI in patient engagement market, by delivery mode, 2018 – 2030 (USD Million)

Table 25 Europe AI in patient engagement market, by functionality, 2018 – 2030 (USD Million)

Table 26 Europe AI in patient engagement market, by technology, 2018 – 2030 (USD Million)

Table 27 Europe AI in patient engagement market, by therapeutic area, 2018 – 2030 (USD Million)

Table 28 Europe AI in patient engagement market, by end-use, 2018 – 2030 (USD Million)

Table 29 Germany AI in patient engagement market, by delivery mode, 2018 – 2030 (USD Million)

Table 30 Germany AI in patient engagement market, by functionality, 2018 – 2030 (USD Million)

Table 31 Germany AI in patient engagement market, by technology, 2018 – 2030 (USD Million)

Table 32 Germany AI in patient engagement market, by therapeutic area, 2018 – 2030 (USD Million)

Table 33 Germany AI in patient engagement market, by end-use, 2018 – 2030 (USD Million)

Table 34 UK AI in patient engagement market, by delivery mode, 2018 – 2030 (USD Million)

Table 35 UK AI in patient engagement market, by functionality, 2018 – 2030 (USD Million)

Table 36 UK AI in patient engagement market, by technology, 2018 – 2030 (USD Million)

Table 37 UK AI in patient engagement market, by therapeutic area, 2018 – 2030 (USD Million)

Table 38 UK AI in patient engagement market, by end-use, 2018 – 2030 (USD Million)

Table 39 France AI in patient engagement market, by delivery mode, 2018 – 2030 (USD Million)

Table 40 France AI in patient engagement market, by functionality, 2018 – 2030 (USD Million)

Table 41 France AI in patient engagement market, by technology, 2018 – 2030 (USD Million)

Table 42 France AI in patient engagement market, by therapeutic area, 2018 – 2030 (USD Million)

Table 43 France AI in patient engagement market, by end-use, 2018 – 2030 (USD Million)

Table 44 Italy AI in patient engagement market, by delivery mode, 2018 – 2030 (USD Million)

Table 45 Italy AI in patient engagement market, by functionality, 2018 – 2030 (USD Million)

Table 46 Italy AI in patient engagement market, by technology, 2018 – 2030 (USD Million)

Table 47 Italy AI in patient engagement market, by therapeutic area, 2018 – 2030 (USD Million)

Table 48 Italy AI in patient engagement market, by end-use, 2018 – 2030 (USD Million)

Table 49 Spain AI in patient engagement market, by delivery mode, 2018 – 2030 (USD Million)

Table 50 Spain AI in patient engagement market, by functionality, 2018 – 2030 (USD Million)

Table 51 Spain AI in patient engagement market, by technology, 2018 – 2030 (USD Million)

Table 52 Spain AI in patient engagement market, by therapeutic area, 2018 – 2030 (USD Million)

Table 53 Spain AI in patient engagement market, by end-use, 2018 – 2030 (USD Million)

Table 54 Denmark AI in patient engagement market, by delivery mode, 2018 – 2030 (USD Million)

Table 55 Denmark AI in patient engagement market, by functionality, 2018 – 2030 (USD Million)

Table 56 Denmark AI in patient engagement market, by technology, 2018 – 2030 (USD Million)

Table 57 Denmark AI in patient engagement market, by therapeutic area, 2018 – 2030 (USD Million)

Table 58 Denmark AI in patient engagement market, by end-use, 2018 – 2030 (USD Million)

Table 59 Sweden AI in patient engagement market, by delivery mode, 2018 – 2030 (USD Million)

Table 60 Sweden AI in patient engagement market, by functionality, 2018 – 2030 (USD Million)

Table 61 Sweden AI in patient engagement market, by technology, 2018 – 2030 (USD Million)

Table 62 Sweden AI in patient engagement market, by therapeutic area, 2018 – 2030 (USD Million)

Table 63 Sweden AI in patient engagement market, by end-use, 2018 – 2030 (USD Million)

Table 64 Norway AI in patient engagement market, by delivery mode, 2018 – 2030 (USD Million)

Table 65 Norway AI in patient engagement market, by functionality, 2018 – 2030 (USD Million)

Table 66 Norway AI in patient engagement market, by technology, 2018 – 2030 (USD Million)

Table 67 Norway AI in patient engagement market, by therapeutic area, 2018 – 2030 (USD Million)

Table 68 Norway AI in patient engagement market, by end-use, 2018 – 2030 (USD Million)

Table 69 Asia Pacific AI in patient engagement market, by region, 2018 – 2030 (USD Million)

Table 70 Asia Pacific AI in patient engagement market, by delivery mode, 2018 – 2030 (USD Million)

Table 71 Asia Pacific AI in patient engagement market, by functionality, 2018 – 2030 (USD Million)

Table 72 Asia Pacific AI in patient engagement market, by technology, 2018 – 2030 (USD Million)

Table 73 Asia Pacific AI in patient engagement market, by therapeutic area, 2018 – 2030 (USD Million)

Table 74 Asia Pacific AI in patient engagement market, by end-use, 2018 – 2030 (USD Million)

Table 75 China AI in patient engagement market, by delivery mode, 2018 – 2030 (USD Million)

Table 76 China AI in patient engagement market, by functionality, 2018 – 2030 (USD Million)

Table 77 China AI in patient engagement market, by technology, 2018 – 2030 (USD Million)

Table 78 China AI in patient engagement market, by therapeutic area, 2018 – 2030 (USD Million)

Table 79 China AI in patient engagement market, by end-use, 2018 – 2030 (USD Million)

Table 80 Japan AI in patient engagement market, by delivery mode, 2018 – 2030 (USD Million)

Table 81 Japan AI in patient engagement market, by functionality, 2018 – 2030 (USD Million)

Table 82 Japan AI in patient engagement market, by technology, 2018 – 2030 (USD Million)

Table 83 Japan AI in patient engagement market, by therapeutic area, 2018 – 2030 (USD Million)

Table 84 Japan AI in patient engagement market, by end-use, 2018 – 2030 (USD Million)

Table 85 India AI in patient engagement market, by delivery mode, 2018 – 2030 (USD Million)

Table 86 India AI in patient engagement market, by functionality, 2018 – 2030 (USD Million)

Table 87 India AI in patient engagement market, by technology, 2018 – 2030 (USD Million)

Table 88 India AI in patient engagement market, by therapeutic area, 2018 – 2030 (USD Million)

Table 89 India AI in patient engagement market, by end-use, 2018 – 2030 (USD Million)

Table 90 South Korea AI in patient engagement market, by delivery mode, 2018 – 2030 (USD Million)

Table 91 South Korea AI in patient engagement market, by functionality, 2018 – 2030 (USD Million)

Table 92 South Korea AI in patient engagement market, by technology, 2018 – 2030 (USD Million)

Table 93 South Korea AI in patient engagement market, by therapeutic area, 2018 – 2030 (USD Million)

Table 94 South Korea AI in patient engagement market, by end-use, 2018 – 2030 (USD Million)

Table 95 Australia AI in patient engagement market, by delivery mode, 2018 – 2030 (USD Million)

Table 96 Australia AI in patient engagement market, by functionality, 2018 – 2030 (USD Million)

Table 97 Australia AI in patient engagement market, by technology, 2018 – 2030 (USD Million)

Table 98 Australia AI in patient engagement market, by therapeutic area, 2018 – 2030 (USD Million)

Table 99 Australia AI in patient engagement market, by end-use, 2018 – 2030 (USD Million)

Table 100 Thailand AI in patient engagement market, by delivery mode, 2018 – 2030 (USD Million)

Table 101 Thailand AI in patient engagement market, by functionality, 2018 – 2030 (USD Million)

Table 102 Thailand AI in patient engagement market, by technology, 2018 – 2030 (USD Million)

Table 103 Thailand AI in patient engagement market, by therapeutic area, 2018 – 2030 (USD Million)

Table 104 Thailand AI in patient engagement market, by end-use, 2018 – 2030 (USD Million)

Table 105 Latin America AI in patient engagement market, by region, 2018 – 2030 (USD Million)

Table 106 Latin America AI in patient engagement market, by delivery mode, 2018 – 2030 (USD Million)

Table 107 Latin America AI in patient engagement market, by functionality, 2018 – 2030 (USD Million)

Table 108 Latin America AI in patient engagement market, by technology, 2018 – 2030 (USD Million)

Table 109 Latin America AI in patient engagement market, by therapeutic area, 2018 – 2030 (USD Million)

Table 110 Latin America AI in patient engagement market, by end-use, 2018 – 2030 (USD Million)

Table 111 Brazil AI in patient engagement market, by delivery mode, 2018 – 2030 (USD Million)

Table 112 Brazil AI in patient engagement market, by functionality, 2018 – 2030 (USD Million)

Table 113 Brazil AI in patient engagement market, by technology, 2018 – 2030 (USD Million)

Table 114 Brazil AI in patient engagement market, by therapeutic area, 2018 – 2030 (USD Million)

Table 115 Brazil AI in patient engagement market, by end-use, 2018 – 2030 (USD Million)

Table 116 Argentina AI in patient engagement market, by delivery mode, 2018 – 2030 (USD Million)

Table 117 Argentina AI in patient engagement market, by functionality, 2018 – 2030 (USD Million)

Table 118 Argentina AI in patient engagement market, by technology, 2018 – 2030 (USD Million)

Table 119 Argentina AI in patient engagement market, by therapeutic area, 2018 – 2030 (USD Million)

Table 120 Argentina AI in patient engagement market, by end-use, 2018 – 2030 (USD Million)

Table 121 MEA AI in patient engagement market, by region, 2018 – 2030 (USD Million)

Table 122 MEA AI in patient engagement market, by delivery mode, 2018 – 2030 (USD Million)

Table 123 MEA AI in patient engagement market, by functionality, 2018 – 2030 (USD Million)

Table 124 MEA AI in patient engagement market, by technology, 2018 – 2030 (USD Million)

Table 125 MEA AI in patient engagement market, by therapeutic area, 2018 – 2030 (USD Million)

Table 126 MEA AI in patient engagement market, by end-use, 2018 – 2030 (USD Million)

Table 127 South Africa AI in patient engagement market, by delivery mode, 2018 – 2030 (USD Million)

Table 128 South Africa AI in patient engagement market, by functionality, 2018 – 2030 (USD Million)

Table 129 South Africa AI in patient engagement market, by technology, 2018 – 2030 (USD Million)

Table 130 South Africa AI in patient engagement market, by therapeutic area, 2018 – 2030 (USD Million)

Table 131 South Africa AI in patient engagement market, by end-use, 2018 – 2030 (USD Million)

Table 132 Saudi Arabia AI in patient engagement market, by delivery mode, 2018 – 2030 (USD Million)

Table 133 Saudi Arabia AI in patient engagement market, by functionality, 2018 – 2030 (USD Million)

Table 134 Saudi Arabia AI in patient engagement market, by technology, 2018 – 2030 (USD Million)

Table 135 Saudi Arabia AI in patient engagement market, by therapeutic area, 2018 – 2030 (USD Million)

Table 136 Saudi Arabia AI in patient engagement market, by end-use, 2018 – 2030 (USD Million)

Table 137 UAE AI in patient engagement market, by delivery mode, 2018 – 2030 (USD Million)

Table 138 UAE AI in patient engagement market, by functionality, 2018 – 2030 (USD Million)

Table 139 UAE AI in patient engagement market, by technology, 2018 – 2030 (USD Million)

Table 140 UAE AI in patient engagement market, by therapeutic area, 2018 – 2030 (USD Million)

Table 141 UAE AI in patient engagement market, by end-use, 2018 – 2030 (USD Million)

Table 142 Kuwait AI in patient engagement market, by delivery mode, 2018 – 2030 (USD Million)

Table 143 Kuwait AI in patient engagement market, by functionality, 2018 – 2030 (USD Million)

Table 144 Kuwait AI in patient engagement market, by technology, 2018 – 2030 (USD Million)

Table 145 Kuwait AI in patient engagement market, by therapeutic area, 2018 – 2030 (USD Million)

Table 146 Kuwait AI in patient engagement market, by end-use, 2018 – 2030 (USD Million)

List of Figures

List of Figures

Fig. 1 Artificial intelligence in patient engagement market segmentation

Fig. 2 Market research process

Fig. 3 Information procurement

Fig. 4 Commodity flow analysis

Fig. 5 Parent market analysis

Fig. 6 Market snapshot

Fig. 7 Segment snapshot

Fig. 8 Segment snapshot

Fig. 9 Segment snapshot

Fig. 10 Competitive landscape snapshot

Fig. 11 AI in Patient Engagement Market Dynamics

Fig. 12 Major chatbot use cases in healthcare

Fig. 13 Advantages of omnichannel for pharmaceutical industry

Fig. 14 Key benefits of patient-centered care:

Fig. 15 Key challenges and strategies to maximize the potential of conversational AI in healthcare

Fig. 16 AI in patient engagement market: Porter’s five forces analysis

Fig. 17 AI in patient engagement market: PESTLE analysis

Fig. 18 AI in patient engagement market, component outlook key takeaways (USD million)

Fig. 19 AI in patient engagement market: Technology movement analysis, 2023 & 2030 (USD Million)

Fig. 20 NLP market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 21 Smart assistance market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 22 OCR market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 23 Auto coding market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 24 Text analytics market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 25 Speech analytics market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 26 Text analytics market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 27 Others market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 28 AI in patient engagement market, therapeutic outlook key takeaways (USD Million)

Fig. 29 AI in patient engagement market: Therapeutic area movement analysis, 2023 & 2030 (USD Million)

Fig. 30 Health & wellness market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 31 Chronic disease management market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 32 Others market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 33 AI in patient engagement market, functionality outlook key takeaways (USD Million)

Fig. 34 AI in patient engagement market: Functionality movement analysis, 2023 & 2030 (USD Million)

Fig. 35 Enhanced communication market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 36 Patient education market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 37 Chatbots and virtual health assistants market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 38 Predictive analytics market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 39 Administrative and streamlined operations market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 40 Others market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 41 AI in patient engagement market, delivery type outlook key takeaways (USD million)

Fig. 42 AI in patient engagement market: Delivery type movement analysis, 2023 & 2030 (USD Million)

Fig. 43 Cloud-based market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 44 On-premise market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 45 AI in patient engagement market, end use outlook key takeaways (USD Million)

Fig. 46 AI in patient engagement market: End use movement analysis, 2023 & 2030 (USD Million)

Fig. 47 Healthcare providers market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 48 Healthcare payers market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 49 Others market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 50 Regional outlook, 2023 & 2030

Fig. 51 Regional marketplace: Key takeaways

Fig. 52 Regional marketplace: Key takeaways

Fig. 53 North America: SWOT Analysis

Fig. 54 North America AI in patient engagement market, 2018 – 2030 (USD Million)

Fig. 55 U.S country dynamics

Fig. 56 U.S. AI in patient engagement market, 2018 – 2030 (USD Million)

Fig. 57 Canada country dynamics

Fig. 58 Canada AI in patient engagement market, 2018 – 2030 (USD Million)

Fig. 59 Mexico country dynamics

Fig. 60 Mexico AI in patient engagement market, 2018 – 2030 (USD Million)

Fig. 61 Europe: SWOT Analysis

Fig. 62 Europe AI in patient engagement market, 2018 – 2030 (USD Million)

Fig. 63 Germany country dynamics

Fig. 64 Germany AI in patient engagement market, 2018 – 2030 (USD Million)

Fig. 65 France country dynamics

Fig. 66 France AI in patient engagement market, 2018 – 2030 (USD Million)

Fig. 67 UK country dynamics

Fig. 68 UK AI in patient engagement market, 2018 – 2030 (USD Million)

Fig. 69 Italy country dynamics

Fig. 70 Italy AI in patient engagement market, 2018 – 2030 (USD Million)

Fig. 71 Spain country dynamics

Fig. 72 Spain AI in patient engagement market, 2018 – 2030 (USD Million)

Fig. 73 Denmark country dynamics

Fig. 74 Denmark AI in patient engagement market, 2018 – 2030 (USD Million)

Fig. 75 Sweden country dynamics

Fig. 76 Sweden AI in patient engagement market, 2018 – 2030 (USD Million)

Fig. 77 Norway country dynamics

Fig. 78 Norway AI in patient engagement market, 2018 – 2030 (USD Million)

Fig. 79 Asia Pacific: SWOT Analysis

Fig. 80 Asia Pacific AI in patient engagement market, 2018 – 2030 (USD Million)

Fig. 81 Japan country dynamics

Fig. 82 Japan AI in patient engagement market, 2018 – 2030 (USD Million)

Fig. 83 China country dynamics

Fig. 84 China AI in patient engagement market, 2018 – 2030 (USD Million)

Fig. 85 India country dynamics

Fig. 86 India AI in patient engagement market, 2018 – 2030 (USD Million)

Fig. 87 Australia country dynamics

Fig. 88 Australia AI in patient engagement market, 2018 – 2030 (USD Million)

Fig. 89 South Korea country dynamics

Fig. 90 South Korea AI in patient engagement market, 2018 – 2030 (USD Million)

Fig. 91 Thailand country dynamics

Fig. 92 Thailand AI in patient engagement market, 2018 – 2030 (USD Million)

Fig. 93 Latin America: SWOT Analysis

Fig. 94 Latin America AI in patient engagement market, 2018 – 2030 (USD Million)

Fig. 95 Brazil country dynamics

Fig. 96 Brazil AI in patient engagement market, 2018 – 2030 (USD Million)

Fig. 97 Argentina country dynamics

Fig. 98 Argentina AI in patient engagement market, 2018 – 2030 (USD Million)

Fig. 99 MEA: SWOT Analysis

Fig. 100 MEA AI in patient engagement market, 2018 – 2030 (USD Million)

Fig. 101 South Africa country dynamics

Fig. 102 South Africa AI in patient engagement market, 2018 – 2030 (USD Million)

Fig. 103 Saudi Arabia country dynamics

Fig. 104 Saudi Arabia AI in patient engagement market, 2018 – 2030 (USD Million)

Fig. 105 UAE country dynamics

Fig. 106 UAE AI in patient engagement market, 2018 – 2030 (USD Million)

Fig. 107 Kuwait country dynamics

Fig. 108 Kuwait AI in patient engagement market, 2018 – 2030 (USD Million)

Fig. 109 Key company categorization

Fig. 110 Company market position analysis

Fig. 111 Strategy mapping

Grand View Researchについて

Grand View Research（グランドビューリサーチ） はインドと米国を拠点とする市場調査およびコンサルティング会社です。世界中主要 25ヵ国・ 46 業界に関する豊富なデータベースを活用した市場情報は世界の企業団体に活用・引用されています。日本からのレポートのご注文・ご購入相談はお気軽にお問い合わせください。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ 1

ライセンスタイプ 2

ライセンスタイプ 3

ライセンスタイプ 4

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス（インディビジュアルライセンス）
    • 1名のみレポートファイル（印刷不可）をご利用いただけます。
  • チームライセンス
    • 同一企業（関連会社除く）内5名まで共有可能です。印刷可能な電子ファイルをご提供いたします。
  • コーポレートライセンス
    • 同一企業および関連会社内で人数無制限で共有可能です。印刷可能な電子ファイルをご提供いたします。
    • 「関連会社」の範囲についてはお気軽にお問い合わせください。
• 納品形態
  • オンラインダウンロード
• 納期
  • ご注文後1～7営業日　※レポートにより異なります。

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

最新出版レポート

• ARクラウド市場規模、成長と動向分析レポート 2025-2033年
• ノーコードAIプラットフォーム市場規模、成長と動向分析レポート 2025-2033年
• 量子コンピューティングにおけるAI最適化市場規模、成長と動向分析レポート 2025-2033年
• ワイヤレス状態監視システム市場規模、成長と動向分析レポート 2025-2033年
• ゲームストリーミング市場規模、成長と動向分析レポート 2025-2033年

出版レポート一覧